mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.01 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.01 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.02 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |